Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome

被引:25
|
作者
Ge, Mengyuan [1 ,2 ]
Molina, Judith [1 ,2 ]
Kim, Jin-Ju [1 ,2 ]
Mallela, Shamroop K. [1 ,2 ]
Ahmad, Anis [3 ]
Varona Santos, Javier [1 ,2 ]
Al-Ali, Hassan [1 ,2 ]
Mitrofanova, Alla [1 ,2 ]
Sharma, Kumar [4 ]
Fontanesi, Flavia [5 ]
Merscher, Sandra [1 ,2 ]
Fornoni, Alessia [1 ,2 ]
机构
[1] Univ Miami, Dept Med, Miller Sch Med, Katz Family Div Nephrol & Hypertens, Miami, FL 33136 USA
[2] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miller Sch Med, Miami, FL 33136 USA
[3] Univ Miami, Dept Radiat Oncol, Miller Sch Med, Miami, FL USA
[4] Univ Texas Hlth San Antonio, Ctr Precis Med, Sch Med, San Antonio, TX USA
[5] Univ Miami, Dept Biochem & Mol Biol, Miami, FL USA
来源
ELIFE | 2023年 / 12卷
基金
美国国家卫生研究院;
关键词
Alport syndrome; lipid; energy substrate; SGLT2; inhibitor; Mouse; COTRANSPORTER; 2; INHIBITION; FATTY-ACID OXIDATION; DIABETIC KIDNEY; CELL-LINES; SGLT2; METABOLISM; EXPRESSION; MUTATIONS; APOPTOSIS; DISEASE;
D O I
10.7554/eLife.83353
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are anti-hyperglycemic agents that prevent glucose reabsorption in proximal tubular cells. SGLT2i improves renal outcomes in both diabetic and non-diabetic patients, indicating it may have beneficial effects beyond glycemic control. Here, we demonstrate that SGLT2i affects energy metabolism and podocyte lipotoxicity in experimental Alport syndrome (AS). In vitro, we found that the SGLT2 protein was expressed in human and mouse podocytes to a similar extent in tubular cells. Newly established immortalized podocytes from Col4a3 knockout mice (AS podocytes) accumulate lipid droplets along with increased apoptosis when compared to wild-type podocytes. Treatment with SGLT2i empagliflozin reduces lipid droplet accumulation and apoptosis in AS podocytes. Empagliflozin inhibits the utilization of glucose/pyruvate as a metabolic substrate in AS podocytes but not in AS tubular cells. In vivo, we demonstrate that empagliflozin reduces albuminuria and prolongs the survival of AS mice. Empagliflozin-treated AS mice show decreased serum blood urea nitrogen and creatinine levels in association with reduced triglyceride and cholesterol ester content in kidney cortices when compared to AS mice. Lipid accumulation in kidney cortices correlates with a decline in renal function. In summary, empagliflozin reduces podocyte lipotoxicity and improves kidney function in experimental AS in association with the energy substrates switch from glucose to fatty acids in podocytes.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] ALPORT-SYNDROME
    SCHONENBERG, H
    MARENBERG, HG
    MONATSSCHRIFT KINDERHEILKUNDE, 1977, 125 (04) : 211 - &
  • [42] Diagnosis of Alport syndrome
    Kashtan, CE
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1290 - 1291
  • [43] Alport's Syndrome
    Akalin, Tayfun
    Ayli, M. Deniz
    Abayli, Ekrem
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2006, 15 (01): : 13 - 21
  • [44] A CASE OF ALPORT SYNDROME
    SHISHKIN, AN
    ZUS, BA
    PEVZNER, AS
    TERAPEVTICHESKII ARKHIV, 1985, 57 (09) : 135 - 136
  • [45] ALPORT SYNDROME WITH ABSENCES
    SPATZ, R
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1974, 36 (01): : 90 - 91
  • [46] ALPORT SYNDROME AND THE EYE
    MCCARTNEY, PJ
    MCGUINNESS, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1989, 17 (02): : 165 - 168
  • [47] Women and Alport syndrome
    Michelle N. Rheault
    Pediatric Nephrology, 2012, 27 : 41 - 46
  • [48] ALPORT'S SYNDROME
    MILLER, GW
    JOSEPH, DJ
    COZAD, RL
    MCCABE, BF
    ARCHIVES OF OTOLARYNGOLOGY, 1970, 92 (05): : 419 - +
  • [49] Women and Alport syndrome
    Rheault, Michelle N.
    PEDIATRIC NEPHROLOGY, 2012, 27 (01) : 41 - 46
  • [50] Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome
    Prodromidi, Evangelia I.
    Poulsom, Richard
    Jeffery, Rosemary
    Roufosse, Candice A.
    Pollard, Patrick J.
    Pusey, Charles D.
    Cook, H. Terence
    STEM CELLS, 2006, 24 (11) : 2448 - 2455